Shanghai Fosun Pharmaceutical Group Co Ltd
SSE:600196

Watchlist Manager
Shanghai Fosun Pharmaceutical Group Co Ltd Logo
Shanghai Fosun Pharmaceutical Group Co Ltd
SSE:600196
Watchlist
Price: 26.24 CNY -3.78% Market Closed
Market Cap: 67.1B CNY
Have any thoughts about
Shanghai Fosun Pharmaceutical Group Co Ltd?
Write Note

Relative Value

The Relative Value of one Shanghai Fosun Pharmaceutical Group Co Ltd stock under the Base Case scenario is 53.63 CNY. Compared to the current market price of 26.24 CNY, Shanghai Fosun Pharmaceutical Group Co Ltd is Undervalued by 51%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
53.63 CNY
Undervaluation 51%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
76
vs Industry
60
Median 3Y
1.9
Median 5Y
2.3
Industry
2.5
Forward
1.6
vs History
7
vs Industry
14
Median 3Y
26.1
Median 5Y
26.7
Industry
21.9
Forward
30.3
vs History
63
vs Industry
23
Median 3Y
21.3
Median 5Y
22.4
Industry
16.5
vs History
vs Industry
3
Median 3Y
36.1
Median 5Y
28.2
Industry
23.6
vs History
82
vs Industry
51
Median 3Y
1.9
Median 5Y
2.1
Industry
2.1
vs History
69
vs Industry
52
Median 3Y
2.2
Median 5Y
2.7
Industry
2.6
Forward
2
vs History
57
vs Industry
47
Median 3Y
4.6
Median 5Y
5.1
Industry
5.2
vs History
36
vs Industry
4
Median 3Y
50.6
Median 5Y
50.6
Industry
13.3
Forward
13.9
vs History
36
vs Industry
5
Median 3Y
50.6
Median 5Y
50.6
Industry
16.6
Forward
29.6
vs History
55
vs Industry
20
Median 3Y
24.5
Median 5Y
25.6
Industry
15.6
vs History
vs Industry
Median 3Y
-60.3
Median 5Y
-89.6
Industry
19.1
vs History
82
vs Industry
63
Median 3Y
1.1
Median 5Y
1.2
Industry
1.9

Multiples Across Competitors

Competitors Multiples
Shanghai Fosun Pharmaceutical Group Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Shanghai Fosun Pharmaceutical Group Co Ltd
SSE:600196
70.1B CNY 1.7 38.2 53.5 53.5
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7

See Also

Discover More
Back to Top